Corticosteroids Global Market Report 2025

Description

Corticosteroid therapy involves administering treatment in various forms to suppress the immune system and alleviate inflammation. It is employed in addressing conditions such as asthma, hay fever, and urticaria (hives) associated with allergy symptoms. Corticosteroids, also referred to as steroids, represent a category of anti-inflammatory medications.

The primary classifications of corticosteroid therapy include glucocorticoids and mineralocorticoids. Glucocorticoids, a specific type of corticosteroid hormone, are highly effective in immune system suppression and inflammation reduction. This therapeutic approach finds application in treating skin allergies, rheumatology indications, endocrinology, and acute respiratory diseases in medical facilities, clinics, research institutes, and other healthcare settings.

The corticosteroids therapy market research report is one of a series of new reports from The Business Research Company that provides corticosteroids therapy market statistics, including corticosteroids therapy industry global market size, regional shares, competitors with a corticosteroids therapy market share, detailed corticosteroids therapy market segments, market trends and opportunities, and any further data you may need to thrive in the corticosteroids therapy industry. This corticosteroid therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The corticosteroids market size has grown steadily in recent years. It will grow from $5.47 billion in 2024 to $5.7 billion in 2025 at a compound annual growth rate (CAGR) of 4.1%. The growth in the historic period can be attributed to treatment of inflammatory conditions, autoimmune disorders and immune system suppression, respiratory conditions and asthma management, allergic reactions and dermatological applications, cancer treatment support.

The corticosteroids market size is expected to see strong growth in the next few years. It will grow to $7.24 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to rising incidence of chronic diseases, expanding applications in rheumatology, advancements in drug delivery, geriatric population growth, research and development in corticosteroid therapeutics. Major trends in the forecast period include immunomodulatory effects emphasis, biosimilar market growth, combination therapies development, pediatric-specific formulations, regulatory compliance focus.

The growing demand for cancer treatment is expected to drive the expansion of the corticosteroid market in the coming years. Cancer treatment includes various therapies-such as surgery, chemotherapy, radiation therapy, immunotherapy, and targeted treatments-aimed at eliminating cancer cells and alleviating symptoms. Several factors contribute to the increasing demand for cancer treatment, including the rising incidence of cancer, enhanced awareness and screening efforts, better access to healthcare, and the availability of supportive care services. Corticosteroids help alleviate symptoms and improve the tolerability of cancer treatments, which leads to better patient outcomes and further supports the demand for comprehensive cancer care. For example, in May 2024, the National Health Service (NHS) in the UK reported that treatment activity reached an all-time high, with over 1,400 patients beginning cancer treatment each working day. From April 2023 to March 2024, nearly 340,000 individuals received their first cancer treatment. Consequently, the increasing demand for cancer treatment is propelling the growth of the corticosteroid market.

The rising prevalence of respiratory diseases is anticipated to drive the growth of the corticosteroids market in the future. Corticosteroids are commonly prescribed for conditions such as rhinitis, pneumonitis, sarcoidosis, asthma exacerbations, COPD exacerbations, anaphylaxis, urticaria, and angioedema. Many respiratory ailments, including asthma and COPD exacerbations, anaphylaxis, urticaria and angioedema, rhinitis, pneumonitis, sarcoidosis, and interstitial lung disease, are treated with corticosteroids. For example, in May 2024, Asthma Australia, a national not-for-profit organization, reported that asthma mortality rates in Australia rose from 349 deaths in 2021 to 455 deaths in 2022, highlighting a concerning trend regarding this chronic respiratory condition. As a result, the increasing incidence of respiratory diseases is propelling the corticosteroids market forward.

An emerging trend in the corticosteroid therapy market is the development of silicones for topical and transdermal drug delivery. Silicone gel sheets and implants are being used to deliver drugs effectively, and silicone-based pressure-sensitive adhesives for transdermal drug delivery show promising results. Silicones offer advantages such as improved drug permeability and high diffusivity, making them efficient for modern drug products.

Major companies in the corticosteroid market are focusing on innovation to expand their customer bases and increase revenue. The development of rescue medications, such as AstraZeneca's Airsupra, indicates a commitment to meeting immediate relief needs for acute symptoms. AstraZeneca's product, a fixed-dose combination rescue medication, received FDA approval in January 2023, containing albuterol and budesonide for bronchoconstriction treatment and asthma exacerbation prevention.

In June 2024, Sun Pharmaceutical Industries Ltd., a specialty generic pharmaceutical company based in India, acquired Taro Pharmaceutical Industries Ltd. for an undisclosed amount. This acquisition aims to enhance Sun Pharma's position in the pharmaceutical market, particularly in the sectors of off-patent pharmaceuticals, prescription medications, and over-the-counter products. Taro Pharmaceutical Industries Ltd., located in Israel, is a research-focused pharmaceutical manufacturer that produces a range of products, including corticosteroids.

Major companies operating in the corticosteroids market include McKesson Corporation, Pfizer Inc., Johnson and Johnson Services Inc., Merck & Co.Inc., Bayer AG, Sumitomo Corporation, Novartis International AG., Sanofi SA, Bristol Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Cipla Limited, Dr. Reddy's Laboratories Ltd., Endo International plc, Lupin Limited, Mallinckrodt Pharmaceuticals Ltd., LEO Pharma A/S, Glenmark Pharmaceuticals Ltd., Wockhardt Limited, Indivior plc, Zizhu Pharmaceutical Co. Ltd., Allergan plc, Hikma Pharmaceuticals plc

North America was the largest region in the corticosteroids therapy market share in 2024. Middle East is expected to be the largest growing region in the global corticosteroids market during the forecast period. The regions covered in the corticosteroids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the corticosteroids market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The corticosteroids therapy market consists of sales of glucocorticoids, mineralocorticoids, cortisone, hydrocortisone, and prednisone. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Corticosteroids Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on corticosteroids market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for corticosteroids ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The corticosteroids market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product: Glucocorticoids; Mineralocorticoids
2) By Application: Skin Allergies; Rheumatology Indications; Endocrinology; Acute Respiratory Diseases; Other Applications
3) By End User: Hospitals; Clinics; Research Institutes; Other End Users
Subsegments:
1) By Glucocorticoids: Hydrocortisone; Prednisone; Dexamethasone; Methylprednisolone; Triamcinolone; Betamethasone; Other Glucocorticoids
2) By Mineralocorticoids: Fludrocortisone; Aldosterone; Other Mineralocorticoids
Companies Mentioned: McKesson Corporation; Pfizer Inc.; Johnson and Johnson Services Inc.; Merck & Co.Inc.; Bayer AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r32991

1. Executive Summary

2. Corticosteroids Market Characteristics

3. Corticosteroids Market Trends And Strategies

4. Corticosteroids Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Corticosteroids Growth Analysis And Strategic Analysis Framework

5.1. Global Corticosteroids PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Corticosteroids Market Growth Rate Analysis
5.4. Global Corticosteroids Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Corticosteroids Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Corticosteroids Total Addressable Market (TAM)

6. Corticosteroids Market Segmentation

6.1. Global Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Glucocorticoids
Mineralocorticoids
6.2. Global Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Skin Allergies
Rheumatology Indications
Endocrinology
Acute Respiratory Diseases
Other Applications
6.3. Global Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Research Institutes
Other End Users
6.4. Global Corticosteroids Market, Sub-Segmentation Of Glucocorticoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hydrocortisone
Prednisone
Dexamethasone
Methylprednisolone
Triamcinolone
Betamethasone
Other Glucocorticoids
6.5. Global Corticosteroids Market, Sub-Segmentation Of Mineralocorticoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fludrocortisone
Aldosterone
Other Mineralocorticoids

7. Corticosteroids Market Regional And Country Analysis

7.1. Global Corticosteroids Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Corticosteroids Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Corticosteroids Market

8.1. Asia-Pacific Corticosteroids Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Corticosteroids Market

9.1. China Corticosteroids Market Overview
9.2. China Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Corticosteroids Market

10.1. India Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Corticosteroids Market

11.1. Japan Corticosteroids Market Overview
11.2. Japan Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Corticosteroids Market

12.1. Australia Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Corticosteroids Market

13.1. Indonesia Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Corticosteroids Market

14.1. South Korea Corticosteroids Market Overview
14.2. South Korea Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Corticosteroids Market

15.1. Western Europe Corticosteroids Market Overview
15.2. Western Europe Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Corticosteroids Market

16.1. UK Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Corticosteroids Market

17.1. Germany Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Corticosteroids Market

18.1. France Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Corticosteroids Market

19.1. Italy Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Corticosteroids Market

20.1. Spain Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Corticosteroids Market

21.1. Eastern Europe Corticosteroids Market Overview
21.2. Eastern Europe Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Corticosteroids Market

22.1. Russia Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Corticosteroids Market

23.1. North America Corticosteroids Market Overview
23.2. North America Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Corticosteroids Market

24.1. USA Corticosteroids Market Overview
24.2. USA Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Corticosteroids Market

25.1. Canada Corticosteroids Market Overview
25.2. Canada Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Corticosteroids Market

26.1. South America Corticosteroids Market Overview
26.2. South America Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Corticosteroids Market

27.1. Brazil Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Corticosteroids Market

28.1. Middle East Corticosteroids Market Overview
28.2. Middle East Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Corticosteroids Market

29.1. Africa Corticosteroids Market Overview
29.2. Africa Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Corticosteroids Market Competitive Landscape And Company Profiles

30.1. Corticosteroids Market Competitive Landscape
30.2. Corticosteroids Market Company Profiles
- 30.2.1. McKesson Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Johnson and Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Corticosteroids Market Other Major And Innovative Companies

31.1. Sumitomo Corporation
31.2. Novartis International AG
31.3. Sanofi SA
31.4. Bristol Myers Squibb Company
31.5. AstraZeneca plc
31.6. Abbott Laboratories
31.7. GlaxoSmithKline plc
31.8. Takeda Pharmaceutical Company Limited
31.9. Eli Lilly and Company
31.10. Boehringer Ingelheim International GmbH
31.11. Novo Nordisk A/S
31.12. Teva Pharmaceutical Industries Ltd.
31.13. Regeneron Pharmaceuticals Inc.
31.14. Sun Pharmaceutical Industries Ltd.
31.15. Cipla Limited

32. Global Corticosteroids Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Corticosteroids Market

34. Recent Developments In The Corticosteroids Market

35. Corticosteroids Market High Potential Countries, Segments and Strategies

35.1 Corticosteroids Market In 2029 - Countries Offering Most New Opportunities
35.2 Corticosteroids Market In 2029 - Segments Offering Most New Opportunities
35.3 Corticosteroids Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer